New Blog Posts:

  • More Than Engaging with Government — Let's Work Together (Report from Victoria Visit)
  • Future of Companion Diagnostics (Report from Chairing a Diagnostics Conference in Europe)

Upcoming Events:

  • LifeSciences BC McCarthy Spotlight Speaking Series (November 9, 2017 — Vancouver, BC)
  • Medica 2017: World Forum for Medicine (November 13-16, 2017 — Düsseldorf, Germany)
Past Featured Events: 
  • Cascadia Venture Forum - Vancouver Regional Forum (October 12, 2017 — Vancouver, BC)
  • How to be Strategic in Partnerships & Raise Investments - seminar by Innovation Boulevard (October 13, 2017 — Surrey, BC)
  • BioTech Pharma Summit 2017: Companion Diagnostics & Biomarkers (October 26-27, 2017 — Porto, Portugal)

New Blog Posts

More Than Engaging with Government - Let's Work Together

On November 2, 2017, I had the pleasure and opportunity to represent LifeSciences BC board, together with Nancy Harrison, Chair, Board of Directors, Dr. Lesley Esford, President & CEO, along with other board members, Dr. Pieter Cullis and Scott Phillips. Our visit included breakfast with the NDP caucus and lunch with the Liberal caucus, where Dr. Esford presented an overview of the life sciences sector in B.C.

What we shared with government were several impressive and enlightening facts:

Continue reading >
Future of Companion Diagnostics
Report from Chairing a Diagnostics Conference in Europe

On October 26-27, I co-chaired an International Conference on “Companion Diagnostics & Biomarkers” in Porto, Portugal.

The presenters included global experts in diagnostics including market leaders such as Unilabs, Agilent, Qiagen, ThermoFisher and Guardant Health.

The Conference was initiated by the other Co-chair, Harry Glorikian, the author of Moneyball Medicine who delivered an engaging presentation predicting the future of medicine and digital health.

Throughout the two days, impressive and informative presentations described the current status and the predicted future of diagnostics and digital health technology including the anticipated tsunami of future changes.

I initiated the second day of the conference with an overview of the past, present and future of diagnostics, encompassing the best (and worst) examples of companion diagnostics (“The Good, the Bad and the Ugly”).

Click here to request the presentation

Here are some summarized highlights from the conference:

Continue reading >

Upcoming Events: Don't Miss Out

LifeSciences BC McCarthy Spotlight Speaking Series
Event topic: Beyond the Science, Who is Your Market?

November 9, 2017 — Vancouver, BC

Held twice a year, the Speaking Series events start with presentations on specific topics by local representatives of LifeSciences BC members. In the past, the series has featured topics focusing on attracting and keeping good talent, technology and licensing, M&A and Capital Markets, to name a few.

Ian Ball: Chief Commercial Officer, Aequus Pharmaceuticals 
Patricia Beckmann: Vice President, Commercialization of Life Science Washington
Norma Biln: CEO of Augurex Life Sciences
Paul Brennan: Vice President, Business Development of Aquinox Pharmaceuticals
Gina Stetsko: Head, Product Development and Manufacturing of Novateur Ventures

More information and registration >
Gina G. Stetsko, PhD
Head of Product Development & Manufacturing
Novateur Ventures
"My talk on Thursday at the LifeSciences BC event is about my career story. It’s a story that involves starting a career as someone who wanted to do research so she could deal with data more often than people and the eventual transformation into someone who loves working with others above all else.

Over 32 years, the Pharma industry has presented me with more than my share of challenges. I often had to execute huge projects with a lot at stake, with very little direct experience with the assigned tasks. Despite this, I succeeded most of the time."
Medica 2017: World Forum for Medicine

November 13-16, 2017 — Düsseldorf, Germany

MEDICA is the world’s largest event for the medical sector. For more than 40 years it has been firmly established on every expert’s calendar. There are many reasons why MEDICA is so unique. Firstly, the event is the largest medical trade fair in the world – in 2016 it attracted more than 5,100 exhibitors from 70 countries in 17 halls.
Novateur team is looking forward to attending Medica 2017.
More information and registration >

Featured Past Events

October 12, 2017 — Vancouver, BC: Ali Ardakani was be a panelist at the Cascadia Venture Forum - Vancouver Regional Forum. The Panel Topic was Building Value and Preparing for an Exit – What Exit Partners are Looking.
More information about the event >

Photo credit: Cascadia Venture Forum - Vancouver

We are delighted to announce that Ali Ardakani, Managing Director of Novateur Ventures has become the Enterpreuner in Residence of Innovation Boulevard. Health Tech Accelerator Innovation Boulevard is an agile partnership of health, business, higher education and government creating new health technologies to improve peoples’ lives.
Ali Ardakani was the featured speaker at the Innovation Boulevard's seminar CheckMate! How to be Strategic in Partnerships & Raise Investments.
More information about the event >

Photo credit: Innovation Boulevard

The innovative B2B event enables the participants to learn about the latest trends, developments, business models and strategies in the companion diagnostics & biomarkers. Ali Ardakani, Managing Director of Novateur Ventures, was a speaker as well as co-chaired the BioTech Pharma Summit 2017.
In his presentation Ali Ardakani was looking at several best cases (and worst cases) of challenges of developing companion diagnostics and how the faith of both the drug and diagnostics changed based the clinical outcome. He talked about the best practices of companion diagnostics for better drug development and successful reimbursement.
Click here to request the presentation >
More information about the event>

More Articles

How to Climb the Life Sciences Mountain

The challenges facing the life sciences sector are well documented, even if there is some debate about which ones are most urgent. From cost and pricing pressures to regulatory compliance, the barriers to success can be significant.
As a result, the mantra “fail it fast” has become a truism. The journey to commercialization is long and expensive; if something isn’t going to succeed, it’s better to know early so that scientists and investors can move on to the next project.
But what about innovations that fail because the teams behind them were missing critical knowledge? How many promising products would live to see the market if their journey was guided by experts who had travelled the route before?

Read in Insights magazine >
Download Novateur article >
Get in Touch
Download Novateur presentation >

Call Us
+1 844 200 6682 (NOVA)
Toll Free USA & Canada

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Novateur Ventures Inc. · 1055 West Georgia Street · Suite 2100 · Vancouver, BC V6E 3P3 · Canada

Email Marketing Powered by Mailchimp